TA179: Gastrointestinal stromal tumours - sunitinib
This is a discussion on TA179: Gastrointestinal stromal tumours - sunitinib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Gastrointestinal stromal tumours - sunitinib. It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 11:51 AM
|
|||
|
|||
TA179: Gastrointestinal stromal tumours - sunitinib
The summary for the published technology appraisal on Gastrointestinal stromal tumours - sunitinib. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA86: Gastro-intestinal stromal tumours (GIST) - imatinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 11:51 AM |
| Doubling of Risk for Bleeding With Sorafenib and Sunitinib | industry_news | Other Clinical Pharmacy News | 0 | 10-27-2009 12:09 PM |
| TA179: Gastrointestinal stromal tumours - sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 09-22-2009 07:06 PM |
| SSRIs and Venlafaxine Linked to Greater Risk for Gastrointestinal Tract Bleeding | industry_news | Other Clinical Pharmacy News | 0 | 07-14-2008 05:31 PM |
| Off-Label Uses of Sorafenib and Sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 03-10-2008 03:01 PM |
© 2008 DrugManagementForum™ powered by |
 |